Neurocrine Biosciences
NBIX
#1510
Rank
$9.37 B
Marketcap
$97.05
Share price
0.00%
Change (1 day)
3.70%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

P/S ratio for Neurocrine Biosciences (NBIX)

P/S ratio as of March 2023 (TTM): 6.30

According to Neurocrine Biosciences 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.29667. At the end of 2022 the company had a P/S ratio of 7.71.

P/S ratio history for Neurocrine Biosciences from 2001 to 2022

PS ratio at the end of each year

Year P/S ratio Change
20227.718.2%
20217.13-16.75%
20208.56-31.97%
201912.6-12.41%
201814.4-66.18%
201742.5-81.05%
2016224-9.2%
2015247
2014N/A-100%
20132162204.11%
20129.3554.16%
20116.07-51.52%
201012.5-69.11%
200940.530.41%
200831.1-78.11%
20071421310.15%
200610.1-46.46%
200518.8-11.08%
200421.152.7%
200313.8-82.15%
200277.6105.49%
200137.8

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
2.26-64.07%๐Ÿ‡บ๐Ÿ‡ธ USA
4.79-23.97%๐Ÿ‡บ๐Ÿ‡ธ USA
11.2 77.31%๐Ÿ‡บ๐Ÿ‡ธ USA
11.6 83.91%๐Ÿ‡บ๐Ÿ‡ธ USA
3.82-39.34%๐Ÿ‡บ๐Ÿ‡ธ USA
2.12-66.30%๐Ÿ‡บ๐Ÿ‡ธ USA
11.9 89.72%๐Ÿ‡บ๐Ÿ‡ธ USA
7.42 17.81%๐Ÿ‡ฌ๐Ÿ‡ง UK